Counterfeit Medicines: Survey Report
Counterfeit medicines pose an ever-greater threat to public health in Europe today. In an effort to adequately measure the scope of the phenomenon and reduce the inherent risks, the Council of Europe has commissioned a survey on issues related to this particularly disquieting form of fraud. This report covers, among others, the current and estimated market and trade matters; the status of pharmaceutical regulation; national and international co-operation between authorities, the industry and wholesalers; detection systems and procedures; the adequacy of legal, judicial and administrative systems and professional training in the matter. It also sets out to define counterfeit medicine and pharmaceutical crime.
What people are saying - Write a review
We haven't found any reviews in the usual places.
distribution storage and importexporttransit of active pharmaceutical
National regulatory authority cooperation
Regulatory authority industry and wholesaler cooperation
Authorities systems and procedures for detection
Legal provisions enforcement sanctions and judicial and intellectual
Adequacy of legaljudicialadministrative systems for dealing with
Counterfeit medicine and pharmaceutical crime definitions
Discussion and final conclusions
Recommendations for the implementation of legislative
Other editions - View all
active administrative anabolic steroids anti-counterfeiting API manufacturers applicable to counterfeit co-operation Colombia comments received Council of Europe counterfeit drugs counterfeit medicinal products counterfeit medicine problem counterfeit pharmaceuticals counterfeit products counterfeiting and counterfeit counterfeiting practices customs authorities definition of counterfeit distribution chain distributors drugs EC Regulation enforcement Europe member European co-ordinating example exist feiting health authorities health risk illegal implementation industry infringement inspection Internet pharmacy investigation involved issue law on medicines licence medicinal products medicines counterfeiting Member state survey Metamizole Ministry MoET MoFTC MoH/DRA MoIP national authorities Number of respondents offences OMCL packaging parallel imports Penal Code penalties pharmaceutical crime pharmacovigilance police procedures prosecution public health relevant repackaging reporting systems responses rights holder sanctions Sildenafil Specific national legislation Stakeholder survey supply chain suspected counterfeit medicines Table tablets Tadalafil types Unknown Unknown unlicensed medicines Viagra wholesalers Yes No Yes Yes Yes Yes